Treating lung disease in infants

May 15, 2014 by Constanze Böttcher, Youris.com

Steroids used to treat the lungs of preterm infants have come under scrutiny. Now a large clinical trial assesses whether inhaling steroids is safe and useful.

The of neonates has advanced considerably in the last decades. But very early are still at risk of dying. Artificial ventilation or additional oxygen is often needed to support the lungs of the . But these measures may also cause other problems. For example, may develop a called bronchopulmonary dysplasia (BPD). The EU-funded project NEUROSIS, due to be completed in 2015, aims at assessing the potential risks and benefits of so-called inhaled steroids to treat BPD. Across European hospitals, a large clinical trial on preterm infants born between the 23rd and 27th week of pregnancy is conducted. Here, project coordinator Christian Poets medical director of the department of neonatology at University Children's Hospital Tübingen, Germany talks to youris.com about the need for such a clinical trial. And why the study's results will be useful regardless of the outcome.

Why is it important to study inhaled steroids in preterm infants?

About 20% of very low birth-weight preterm infants are at risk of developing chronic lung disease. This so-called bronchopulmonary dysplasia (BPD) is an inflammatory disease. Therefore, steroids were used for many years to prevent BPD. But if these steroids are administered via the blood intravenously they may cause an increased risk of cerebral palsy. This means that the child may develop movement disorders that lasts its entire life. Therefore, the use of these so-called systemic steroids has decreased drastically since this risk was detected around the turn of the millennium. Maybe, we paediatricians have even reduced its use to such an extent that more children die. There has always been the option to administer steroids directly to the lung via inhalation. But except for one study, there have not been any larger controlled on inhaled steroids so far.

How was the study designed?

Altogether, we recruited 863 children in 42 study centres. The children had to be enrolled within 12 hours after birth. We chose the dose of the asthma drug budesonide based on the results of the previous study by colleagues in the USA. Neither the clinical team nor the medial researchers knew whether the baby received the drug or a placebo. To exclude any long-term side effects, all infants are checked again at two years of age. The treatment period has now been finished. But we are still analysing the data and collecting data from the two-year follow-up.

Are there alternative ways to prevent lung disease in preterm infants?

Generally, it is a good idea to provide as little as possible. But there are many children where measures such as no ventilation or as gentle ventilation as possible do not suffice. Another effective measure is to treat women who expect a preterm delivery with steroids prior to birth to improve lung maturation of the foetus. This is, for example, well established in Germany. Here, about 95% of women at risk receive such so-called antenatal steroids. But, while this treatment lowers the risk of preterm infants to develop BPD, it does not reduce it to zero.

What is the expected impact of the study?

The results are important in any case. If it turns out that using inhaled steroids can actually lower the rate of BPD in early preterm infants, this will certainly become a routine measure. But if the results are negative, you can avoid an unnecessary and costly treatment in the future. You can even prevent harm by not giving this type of medication.

What motivated you to initiate this study?

It is generally a problem that many medications are not being tested in children. I previously worked on older children with lung diseases that were successfully treated with inhaled steroids. When I started working with neonates and introduced the I faced the dilemma of applying a medication that was not approved. So, when the EU published a list of drugs, including steroids that are used for children but that are not approved, we decided to file an application.

Do you think that more clinical trials should be performed on neonates?

Yes, definitely. We are acting in a black box. We do not really know what we are doing. We treat the most sensitive human beings with medication that is least tested and approved. Of course, the ethics committees have to strictly control such studies. I also think it is important to have these studies funded by public authorities, such as the EU, that take into account the public interest. And not a company's economic interests.

Explore further: Stem cells to treat lung disease in preterm infants

Related Stories

Stem cells to treat lung disease in preterm infants

February 6, 2014
Advances in neonatal care for very preterm infants have greatly increased the chances of survival for these fragile infants. However, preterm infants have an increased risk of developing bronchopulmonary dysplasia (BPD), ...

Prematurity linked to altered lung function during exercise, high blood pressure in adults

April 30, 2014
Advances in medicine have greatly contributed to the survival of extremely preterm infants in the US. However, the picture of long-term health effects related to prematurity is still unclear. Researchers at the University ...

Antibiotic may prove beneficial to preterm infant lung health

April 26, 2011
A study performed by University of Kentucky researchers shows promise for the use of azithromycin in treating Ureaplasma-colonized or infected premature infants to prevent bronchopulmonary dysplasia (BPD).

Study shows steroids ineffective, possibly harmful in pediatric liver disease

May 3, 2014
A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Current therapies less effective than expected in preventing lung injuries in very premature babies

August 14, 2013
A neonatologist at The Children's Hospital of Philadelphia is the senior author of a large new study that found that current non-invasive techniques for respiratory support are less effective than widely assumed, in reducing ...

Researchers spot molecular control switch for preterm lung disorders

March 20, 2013
(Medical Xpress)—Researchers at Yale School of Medicine have made major discoveries that could lead to new treatments for lung disorders in premature babies. In a mouse study, the team located key molecules that switch ...

Recommended for you

Phone-addicted teens are unhappy, study finds

January 22, 2018
Happiness is not a warm phone, according to a new study exploring the link between adolescent life satisfaction and screen time. Teens whose eyes are habitually glued to their smartphones are markedly unhappier, said study ...

Baby brains help infants figure it out before they try it out

January 17, 2018
Babies often amaze their parents when they seemingly learn new skills overnight—how to walk, for example. But their brains were probably prepping for those tasks long before their first steps occurred, according to researchers.

NeuroNext biomarker study explores natural history of infantile-onset SMA

January 9, 2018
Research led by The Ohio State University Wexner Medical Center to define the natural history of infantile-onset spinal muscular atrophy (SMA) has been "critical" to accelerate the development of effective therapies and hasten ...

No link between childhood lead levels, later criminality

December 27, 2017
(HealthDay)— Exposure to higher levels of lead during early childhood can affect neurological development—but does that mean affected kids are doomed to delinquency?

Early puberty in girls may take mental health toll

December 26, 2017
(HealthDay)—A girl who gets her first menstrual period early in life—possibly as young as 7—has a greater risk for developing depression and antisocial behaviors that last at least into her 20s, a new study suggests.

Technology not taking over children's lives despite screen-time increase

December 21, 2017
With children spending increasing amounts of time on screen-based devices, there is a common perception that technology is taking over their lives, to the detriment and exclusion of other activities. However, new Oxford University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.